Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Synthesis and relaxometric studies of a dendrimer-based pH-responsive MRI contrast agent.

Ali MM, Woods M, Caravan P, Opina AC, Spiller M, Fettinger JC, Sherry AD.

Chemistry. 2008;14(24):7250-8. doi: 10.1002/chem.200800402.

2.

Rotational dynamics account for pH-dependent relaxivities of PAMAM dendrimeric, Gd-based potential MRI contrast agents.

Laus S, Sour A, Ruloff R, Tóth E, Merbach AE.

Chemistry. 2005 May 6;11(10):3064-76.

PMID:
15776490
3.

Poly(amidoamine) dendrimer based MRI contrast agents exhibiting enhanced relaxivities derived via metal preligation techniques.

Nwe K, Bryant LH Jr, Brechbiel MW.

Bioconjug Chem. 2010 Jun 16;21(6):1014-7. doi: 10.1021/bc1000802.

4.

Concentration-independent MRI of pH with a dendrimer-based pH-responsive nanoprobe.

Bhuiyan MP, Aryal MP, Janic B, Karki K, Varma NR, Ewing JR, Arbab AS, Ali MM.

Contrast Media Mol Imaging. 2015 Nov-Dec;10(6):481-6. doi: 10.1002/cmmi.1651. Epub 2015 Jul 14.

5.

A new approach in the preparation of dendrimer-based bifunctional diethylenetriaminepentaacetic acid MR contrast agent derivatives.

Nwe K, Xu H, Regino CA, Bernardo M, Ileva L, Riffle L, Wong KJ, Brechbiel MW.

Bioconjug Chem. 2009 Jul;20(7):1412-8. doi: 10.1021/bc900057z.

6.

Macromolecular MRI contrast agents with small dendrimers: pharmacokinetic differences between sizes and cores.

Kobayashi H, Kawamoto S, Jo SK, Bryant HL Jr, Brechbiel MW, Star RA.

Bioconjug Chem. 2003 Mar-Apr;14(2):388-94.

PMID:
12643749
7.

Synthesis and relaxometry of high-generation (G = 5, 7, 9, and 10) PAMAM dendrimer-DOTA-gadolinium chelates.

Bryant LH Jr, Brechbiel MW, Wu C, Bulte JW, Herynek V, Frank JA.

J Magn Reson Imaging. 1999 Feb;9(2):348-52.

PMID:
10077036
8.
9.

Phosphinic derivative of DTPA conjugated to a G5 PAMAM dendrimer: an 17O and 1H relaxation study of its Gd(III) complex.

Lebdusková P, Sour A, Helm L, Tóth E, Kotek J, Lukes I, Merbach AE.

Dalton Trans. 2006 Jul 28;(28):3399-406. Epub 2006 Apr 19.

PMID:
16832488
10.
11.

In Vivo evaluation of a PAMAM-cystamine-(Gd-DO3A) conjugate as a biodegradable macromolecular MRI contrast agent.

Xu R, Wang Y, Wang X, Jeong EK, Parker DL, Lu ZR.

Exp Biol Med (Maywood). 2007 Sep;232(8):1081-9.

PMID:
17720954
12.

AAZTA-based bifunctional chelating agents for the synthesis of multimeric/dendrimeric MRI contrast agents.

Gugliotta G, Botta M, Tei L.

Org Biomol Chem. 2010 Oct 21;8(20):4569-74. doi: 10.1039/c0ob00096e. Epub 2010 Aug 25.

PMID:
20740241
13.

Dendrimer-based MRI contrast agents: the effects of PEGylation on relaxivity and pharmacokinetics.

Kojima C, Turkbey B, Ogawa M, Bernardo M, Regino CA, Bryant LH Jr, Choyke PL, Kono K, Kobayashi H.

Nanomedicine. 2011 Dec;7(6):1001-8. doi: 10.1016/j.nano.2011.03.007. Epub 2011 Apr 8.

14.

Novel water-soluble and pH-responsive anticancer drug nanocarriers: doxorubicin-PAMAM dendrimer conjugates attached to superparamagnetic iron oxide nanoparticles (IONPs).

Chang Y, Meng X, Zhao Y, Li K, Zhao B, Zhu M, Li Y, Chen X, Wang J.

J Colloid Interface Sci. 2011 Nov 1;363(1):403-9. doi: 10.1016/j.jcis.2011.06.086. Epub 2011 Jul 23.

PMID:
21821262
15.

Dendrimer-based metal chelates: a new class of magnetic resonance imaging contrast agents.

Wiener EC, Brechbiel MW, Brothers H, Magin RL, Gansow OA, Tomalia DA, Lauterbur PC.

Magn Reson Med. 1994 Jan;31(1):1-8.

PMID:
8121264
16.
17.

Pharmacokinetics of Chiral Dendrimer-Triamine-Coordinated Gd-MRI Contrast Agents Evaluated by in Vivo MRI and Estimated by in Vitro QCM.

Miyake Y, Ishikawa S, Kimura Y, Son A, Imai H, Matsuda T, Yamada H, Toshimitsu A, Kondo T.

Sensors (Basel). 2015 Dec 18;15(12):31973-86. doi: 10.3390/s151229900.

18.

Novel liver macromolecular MR contrast agent with a polypropylenimine diaminobutyl dendrimer core: comparison to the vascular MR contrast agent with the polyamidoamine dendrimer core.

Kobayashi H, Kawamoto S, Saga T, Sato N, Hiraga A, Ishimori T, Akita Y, Mamede MH, Konishi J, Togashi K, Brechbiel MW.

Magn Reson Med. 2001 Oct;46(4):795-802.

19.

Gadolinium-labeled peptide dendrimers with controlled structures as potential magnetic resonance imaging contrast agents.

Luo K, Liu G, She W, Wang Q, Wang G, He B, Ai H, Gong Q, Song B, Gu Z.

Biomaterials. 2011 Nov;32(31):7951-60. doi: 10.1016/j.biomaterials.2011.07.006. Epub 2011 Jul 23.

PMID:
21784511
20.

Comparison of dendrimer-based macromolecular contrast agents for dynamic micro-magnetic resonance lymphangiography.

Kobayashi H, Kawamoto S, Choyke PL, Sato N, Knopp MV, Star RA, Waldmann TA, Tagaya Y, Brechbiel MW.

Magn Reson Med. 2003 Oct;50(4):758-66.

Supplemental Content

Support Center